SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy

Live virus neutralization is the gold standard to investigate immunity. This prospective observational study aimed to determine the magnitude of response against the original B.1 lineage and against the BA.5 lineage six months after the third BNT162b2 mRNA vaccine dose in patients with HIV infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Vicenti, Ilaria, Basso, Monica, Pirola, Nicole, Bragato, Beatrice, Rossi, Maria Cristina, Giobbia, Mario, Pascoli, Susanna, Vinci, Antonio, Caputo, Sara, Varasi, Ilenia, Biba, Camilla, Fiaschi, Lia, Zazzi, Maurizio, Parisi, Saverio Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144758/
https://www.ncbi.nlm.nih.gov/pubmed/37112782
http://dx.doi.org/10.3390/vaccines11040871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144758/
https://www.ncbi.nlm.nih.gov/pubmed/37112782
http://dx.doi.org/10.3390/vaccines11040871

Ejemplares similares